array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Mon, 10 Mar 2025 18:20:47 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6Im5kcUsvWHVoZXNKQXpWaEU1SlVaaFE9PSIsInZhbHVlIjoiNjZnSzF4Wkd6VldLWmlGemxnOS9FcitMV2JrNkZzMXRsRUU3ZGIzQzRkMzF1eFJJUGF3QVFqQ0tPbGs3LzcxNnZZcXNsOERtRE1xODhQdE1jSHRLTFYxdDZSSU81aHd4aVp4cmxDblV6MXFGSUd6YTg2NWVROUMwSk9YK3VySzkiLCJtYWMiOiI3ZTZhMWRlYTk1ODU1ZWExYzlmYTJiZjFhNGQzNTBhYmY2MjJjMWU2ZTE0OTNjOGZmYmNlZDY3N2U4OTdlN2VhIiwidGFnIjoiIn0%3D; expires=Mon, 10 Mar 2025 20:20:47 GMT; Max-Age=7200; path=/; secure; samesite=lax"
    1 => "dwaey_session=eyJpdiI6IlZOZ1dXUTNPTmdhVFY2dFBVTEo0bnc9PSIsInZhbHVlIjoiQ245OE1mTm9sVnJCUGVidHRkS2xuRDgvdmt2NkFQc1RDZzNvN1FzQjhjL0E2b05hMllkTDl1NVhZTUE3TVRyczVVTTVBWndnQjVlMHZhNGJXK0JRWVFpb2NtZDBFODh3QVlFTWtIRytXZGFtVEFkSjFHbHhkRnp1K1I2OXRxVDkiLCJtYWMiOiIxYWVjOWQwNjAyODRiMzI1Y2I3YzBlMGEyNjNhZjc0YjJjMWE5YThjYjA0OTkzMTk5ZDA0N2I4Y2MzMDdkNWUzIiwidGFnIjoiIn0%3D; expires=Mon, 10 Mar 2025 20:20:47 GMT; Max-Age=7200; path=/; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6Im5kcUsvWHVoZXNKQXpWaEU1SlVaaFE9PSIsInZhbHVlIjoiNjZnSzF4Wkd6VldLWmlGemxnOS9FcitMV2JrNkZzMXRsRUU3ZGIzQzRkMzF1eFJJUGF3QVFqQ0tPbGs3LzcxNnZZcXNsOERtRE1xODhQdE1jSHRLTFYxdDZSSU81aHd4aVp4cmxDblV6MXFGSUd6YTg2NWVROUMwSk9YK3VySzkiLCJtYWMiOiI3ZTZhMWRlYTk1ODU1ZWExYzlmYTJiZjFhNGQzNTBhYmY2MjJjMWU2ZTE0OTNjOGZmYmNlZDY3N2U4OTdlN2VhIiwidGFnIjoiIn0%3D; expires=Mon, 10-Mar-2025 20:20:47 GMT; path=/; secure"
    1 => "dwaey_session=eyJpdiI6IlZOZ1dXUTNPTmdhVFY2dFBVTEo0bnc9PSIsInZhbHVlIjoiQ245OE1mTm9sVnJCUGVidHRkS2xuRDgvdmt2NkFQc1RDZzNvN1FzQjhjL0E2b05hMllkTDl1NVhZTUE3TVRyczVVTTVBWndnQjVlMHZhNGJXK0JRWVFpb2NtZDBFODh3QVlFTWtIRytXZGFtVEFkSjFHbHhkRnp1K1I2OXRxVDkiLCJtYWMiOiIxYWVjOWQwNjAyODRiMzI1Y2I3YzBlMGEyNjNhZjc0YjJjMWE5YThjYjA0OTkzMTk5ZDA0N2I4Y2MzMDdkNWUzIiwidGFnIjoiIn0%3D; expires=Mon, 10-Mar-2025 20:20:47 GMT; path=/; httponly"
  ]
]
Similar Drugs for CLARAZOLE 2%
